The DOI matches its Crossref record; 502 of the 507 references it cites were found in a registry or an index.
The Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Open accessAbstract
The melanocortin-4 receptor (MC4R) was cloned in 1993 by degenerate PCR; however, its function was unknown. Subsequent studies suggest that the MC4R might be involved in regulating energy homeostasis. This hypothesis was confirmed in 1997 by a series of seminal studies in mice. In 1998, human genetic studies demonstrated that mutations in the MC4R gene can cause monogenic obesity. We now know that mutations in the MC4R are the most common monogenic form of obesity, with more than 150 distinct mutations reported thus far. This review will summarize the studies on the MC4R, from its cloning and tissue distribution to its physiological roles in regulating energy homeostasis, cachexia, cardiovascular function, glucose and lipid homeostasis, reproduction and sexual function, drug abuse, pain perception, brain inflammation, and anxiety. I will then review the studies on the pharmacology of the receptor, including ligand binding and receptor activation, signaling pathways, as well as its regulation. Finally, the pathophysiology of the MC4R in obesity pathogenesis will be reviewed. Functional studies of the mutant MC4Rs and the therapeutic implications, including small molecules in correcting binding and signaling defect, and their potential as pharmacological chaperones in rescuing intracellularly retained mutants, will be highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperphagia and increased adiposity lead to stimulation of POMC neurons and MC4R signalling, whereas energy deficits and weight loss reduce signalling in this pathway191,192.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [191]
In the citing paper
“In the ARC and brainstem, POMC-expressing neurons project to second-order neurons involved in BP regulation (for example, in the paraventricular nucleus (PVN)), where their axons release a-melanocyte-stimulating hormone (aMSH), the endogenous ligand for MC4R191 (FIG. 5a).”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [191]
In the citing paper
“The POMC-MC4R system is a major regulator of energy balance.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [191]
In the citing paper
“MC4R signals mainly through phosphorylation of cAMP and activation of protein kinase A (PKA)191.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [191]
In the citing paper
“The MC4R is a G protein-coupled 7 transmembrane receptor that increases cAMP phosphorylation and activates protein kinase A (PKA) [3, 26, 63]; therefore, blockade of these intracellular pathways attenuates MC4R actions [3, 63].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [3]
In the citing paper
“The MC4R is a G protein-coupled 7 transmembrane receptor that increases cAMP phosphorylation and activates protein kinase A (PKA) [3, 26, 63]; therefore, blockade of these intracellular pathways attenuates MC4R actions [3, 63].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 502
Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index
Dempfle, A., Hinney, A., Heinzel-Gutenbrunner, M., Raab, M., Geller, F., Gudermann, T., Schäfer, H., & Hebebrand, J. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018614 · Cited by 132
Fekete, C., Sarkar, S., Rand, W. M., Harney, J. W., Emerson, C. H., Bianco, A. C., & Lechan, R. M. (2002) · Endocrinology · doi:10.1210/en.2002-220338 · Cited by 131
Differential effects of melanocortin peptides on neural melanocortin receptors.
Adan, R. A. H., Cone, R. D., Burbach, J. P. H., & Gispen, W. H. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09867-0 · Cited by 130
Kask, A., Rägo, L., Mutulis, F., Pähkla, R., Wikberg, J. E. S., & Schiöth, H. B. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8389 · Cited by 129
Agouti-related protein-deficient mice display an age-related lean phenotype
Wortley, K. E., Anderson, K. D., Yasenchak, J., Murphy, A., Valenzuela, D., Diano, S., Yancopoulos, G. D., Wiegand, S. J., & Sleeman, M. W. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.11.004 · Cited by 128
Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist
Pfaus, J. G., Shadiack, A. M., Soest, T. V., Tse, M., & Molinoff, P. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400491101 · Cited by 128
Investigation of the melanocyte stimulating hormones on food intake
Abbott, C. R., Rossi, M., Kim, M.-S., AlAhmed, S. H., Taylor, G. M., Ghatei, M. A., Smith, D. M., & Bloom, S. R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02386-6 · Cited by 127
Ceresa, B. P., & Limbird, L. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43916-6 · Cited by 126
Baranski, T., Herzmark, P., Lichtarge, O., Gerber, B. O., Trueheart, J., Meng, E. C., Iiri, T., Sheikh, S. P., & Bourne, H. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15757 · Cited by 126
Calton, M. A., Ersoy, B. A., Zhang, S., Kane, J. P., Malloy, M. J., Pullinger, C. R., Bromberg, Y., Pennacchio, L. A., Dent, R., McPherson, R., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn431 · Cited by 125
Starvation after AgRP neuron ablation is independent of melanocortin signaling
Wu, Q., Howell, M. P., Cowley, M. A., & Palmiter, R. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712062105 · Cited by 123
Kublaoui, B. M., Holder, J. L., Gemelli, T., & Zinn, A. R. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0483 · Cited by 123
Trülzsch, B., Krohn, K., Wonerow, P., Chey, S., Holzapfel, H., Ackermann, F., Führer, D., & Paschke, R. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000170 · Cited by 122
Functional Characterization of Mutations in Melanocortin-4 Receptor Associated with Human Obesity
Ho, G., & MacKenzie, R. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35816 · Cited by 121
Toda, C., Shiuchi, T., Lee, S. P., Yamato-Esaki, M., Fujino, Y., Suzuki, A., Okamoto, S., & Minokoshi, Y. (2009) · Diabetes · doi:10.2337/db09-0638 · Cited by 120
Melanocortin-4 receptor gene and physical activity in the Québec Family Study
Loos, R. J. F., Rankinen, T., Tremblay, A., Përusse, L., Chagnon, Y. C., & Bouchard, C. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802869 · Cited by 119
Jacobson, P., Ukkola, O. H., Rankinen, T., Snyder, E. E., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., Lönn, L., Cowan, G. S. M., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020568 · Cited by 119
Chaki, S., Hirota, S., Funakoshi, T., Suzuki, Y., Suetake, S., Okubo, T., Ishii, T., Nakazato, A., & Okuyama, S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044826 · Cited by 118
Ringholm, A., Fredriksson, R., Poliakova, N., Yan, Y., Postlethwait, J. H., Larhammar, D., & Schiöth, H. B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00934.x · Cited by 117
da Silva, A. A., Kuo, J. J., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000128421.23499.b9 · Cited by 117
Wirth, M. M., Olszewski, P. K., Yu, C., Levine, A. S., & Giraudo, S. Q. (2001) · Peptides · doi:10.1016/s0196-9781(00)00367-3 · Cited by 115
Involvement of melanocortin-4 receptor in anxiety and depression
Chaki, S., & Okuyama, S. (2005) · Peptides · doi:10.1016/j.peptides.2004.11.029 · Cited by 114
Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function
Kuo, J. J., Silva, A. A., & Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000048194.97428.1a · Cited by 113
Büch, T., Heling, D., Damm, E., Gudermann, T. W., & Breit, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039339 · Cited by 112
Giuliani, D., Mioni, C., Altavilla, D., Leone, S., Bazzani, C., Minutoli, L., Bitto, A., Cainazzo, M. M., Marini, H. R., Zaffe, D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0692 · Cited by 111
The apparent cooperativity of some GPCRs does not necessarily imply dimerization
Chabre, M., Déterre, P., & Antonny, B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.01.003 · Cited by 110
The physiological role of melanocortin receptors
Schiöth, H. B. (2001) · Vitamins and hormones · doi:10.1016/s0083-6729(01)63007-3 · Cited by 109
del Giudice, E. M., Cirillo, G., Nigro, V., Santoro, N., D'Urso, L., Raimondo, P., Cozzolino, D., Scafato, D., & Perrone, L. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801983 · Cited by 108
Folding Efficiency Is Rate-limiting in Dopamine D4 Receptor Biogenesis
Van Craenenbroeck, K., Clark, S. D., Cox, M. J., Oak, J. N., Liu, F., & Van Tol, H. H. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414043200 · Cited by 107
Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells
Mountjoy, K. G., Kong, P. L., TAYLOR, J. A., Willard, D. H., & Wilkison, W. O. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.5.1.11 · Cited by 104
Boswell, T., Li, Q., & Takeuchi, S. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00145-6 · Cited by 103
Vos, T. J., Caracoti, A., Che, J. L., Dai, M., Farrer, C. A., Forsyth, N. E., Drabic, S. V., Horlick, R. A., Lamppu, D., Yowe, D. L., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm034244g · Cited by 103
Constitutive and Agonist-dependent Self-association of the Cell Surface Human Lutropin Receptor
Tao, Y., Johnson, N. B., & Segaloff, D. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311162200 · Cited by 103
Self-citationObesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function
Govaerts, C., Srinivasan, S., Shapiro, A., Zhang, S., Picard, F., Clément, K., Lubrano-Berthelier, C., & Vaisse, C. (2005) · Peptides · doi:10.1016/j.peptides.2004.11.042 · Cited by 103
Kobayashi, H., Ogawa, Y., Shintani, M., Ebihara, K., Shimodahira, M., Iwakura, T., Hino, M., Ishihara, T., Ikekubo, K., Kurahachi, H., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.1.243 · Cited by 103
Chapter 6 Mutations in Melanocortin‐4 Receptor and Human Obesity
Tao, Y. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)88006-x · Cited by 102
Self-citationTao, Y., & Segaloff, D. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0519 · Cited by 102
Self-citationWilliams, D. L., Bowers, R. R., Bartness, T. J., Kaplan, J. M., & Grill, H. J. (2003) · Endocrinology · doi:10.1210/en.2003-0440 · Cited by 102
Segal, J. P., Stallings, N. R., Lee, C. E., Zhao, L., Socci, N. D., Viale, A. J., Harris, T. M., Soares, M. B., Childs, G. J., Elmquist, J. K., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0158-05.2005 · Cited by 102
Melanocortin peptide therapeutics: Historical milestones, clinical studies and commercialization
Hadley, M. E., & Dorr, R. T. (2006) · Peptides · doi:10.1016/j.peptides.2005.01.029 · Cited by 101
Fan, Z., & Tao, Y. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00726.x · Cited by 101
Self-citationTao, Q., & Abood, M. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37469-5 · Cited by 101
Tachibana, T., Sugahara, K., Ohgushi, A., Ando, R., Kawakami, S.-I., Yoshimatsu, T., & Furuse, M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01827-4 · Cited by 100
Definable Somatic Disorders in Overweight Children and Adolescents
Reinehr, T., Hinney, A., de Sousa, G., Austrup, F., Hebebrand, J., & Andler, W. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.01.042 · Cited by 100
Brain effects of melanocortins☆
BERTOLINI, A., Tacchi, R., & Vergoni, A. V. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.10.005 · Cited by 100
Tolle, V., & Low, M. J. (2007) · Diabetes · doi:10.2337/db07-0733 · Cited by 100
Markison, S., Foster, A. C., Chen, C., Brookhart, G., Hesse, A., Hoare, S. R. J., Fleck, B. A., Brown, B. T., & Marks, D. L. (2005) · Endocrinology · doi:10.1210/en.2005-0142 · Cited by 100
Kumar, K. G., Sutton, G. M., Dong, J. Z., Roubert, P., Plas, P., Halem, H. A., Culler, M. D., Yang, H., Dixit, V. D., & Butler, A. A. (2009) · Peptides · doi:10.1016/j.peptides.2009.07.012 · Cited by 98
Adan, R. A. H., & Kas, M. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00130-5 · Cited by 97
The Role of the Agouti-Related Protein in Energy Balance Regulation
Ilnytska, O., & Argyropoulos, G. A. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8104-4 · Cited by 97
Houston, R. D., Cameron, N. D., & Rance, K. A. (2004) · Animal Genetics · doi:10.1111/j.1365-2052.2004.01182.x · Cited by 97
Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats
Hwa, J. J., Ghibaudi, L., Gao, J., & Parker, E. M. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.2.r444 · Cited by 96
Evans, T., McCarthy, K. D., & Harden, T. K. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb06688.x · Cited by 96
Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations
Hebebrand, J., Geller, F., Dempfle, A., Heinzel‐Gutenbrunner, M., Raab, M. S., Gerber, G., Wermter, A. ‐., Horro, F. F., Blundell, J. E., Schäfer, H., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001491 · Cited by 96
Bariohay, B., Roux, J., Tardivel, C., Trouslard, J., Jean, A., & Lebrun, B. (2009) · Endocrinology · doi:10.1210/en.2008-1184 · Cited by 95
Blockade of melanocortin transmission inhibits cocaine reward
Hsu, R., Taylor, J. R., Newton, S. S., Alvaro, J. D., Haile, C. N., Han, G. U., Hruby, V. J., Nestler, E. J., & Duman, R. S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04038.x · Cited by 94
Mice lacking the syndecan-3 gene are resistant to diet-induced obesity
Strader, A. D., Reizes, O., Woods, S. C., Benoit, S. C., & Seeley, R. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20631 · Cited by 94
Caruso, C. M., Durand, D., Schiöth, H. B., Rey, R. A., Seilicovich, A., & Lasaga, M. (2007) · Endocrinology · doi:10.1210/en.2007-0366 · Cited by 94
Sánchez‐Laorden, B. L., Sánchez‐Más, J., Martínez‐Alonso, E., Martínez‐Menárguez, J. A., García-Borrón, J. C., & Jiménez‐Cervantes, C. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700036 · Cited by 94
Interactions of Human Melanocortin 4 Receptor with Nonpeptide and Peptide Agonists,
Pogozheva, I. D., Chai, B.-X., Lomize, A. L., Fong, T. M., Weinberg, D. H., Nargund, R. P., Mulholland, M. W., Gantz, I., & Mosberg, H. I. (2005) · Biochemistry · doi:10.1021/bi0501840 · Cited by 92
Latronico, A. C., Abell, A. N., Arnhold, I. J. P., Liu, X., Lins, T., Brito, V. N., Billerbeck, A. E. C., Segaloff, D. L., & Mendonca, B. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4968 · Cited by 92
Daniels, D., Patten, C. S., Roth, J. D., Yee, D. K., & Fluharty, S. J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03162-7 · Cited by 92
A Homozygous Null Mutation Delineates the Role of the Melanocortin-4 Receptor in Humans
Lubrano-Berthelier, C., Stunff, C. L., Bougneres, P. F., & Vaisse, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031993 · Cited by 92
Mapping of the ACTH, MSH, and neural (MC3 and MC4) melanocortin receptors in the mouse and human
Magenis, R. E., Smith, L. G., Nadeau, J. H., Johnson, K. R., Mountjoy, K. G., & Cone, R. D. (1994) · Mammalian Genome · doi:10.1007/bf00369320 · Cited by 91
Kawakami, S.-I., Bungo, T., Ando, R., Ohgushi, A., Shimojo, M., Masuda, Y., & Furuse, M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00344-7 · Cited by 90
Lu, Z.-L., & Hulme, E. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7309 · Cited by 90
Antagonism of the Melanocortin System Reduces Cold and Mechanical Allodynia in Mononeuropathic Rats
Vrinten, D. H., Gispen, W. H., Groen, G. J., & Adan, R. A. H. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-21-08131.2000 · Cited by 90
Activation of MAP kinase by MC4-R through PI3 kinase
Vongs, A., Lynn, N. M., & Rosenblum, C. I. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.02.018 · Cited by 89
Tan, K. M. L., Pogozheva, I. D., Yeo, G. S. H., Hadaschik, D., Keogh, J. M., Haskell‐Luevano, C., O’Rahilly, S., Mosberg, H. I., & Farooqi, I. S. (2008) · Endocrinology · doi:10.1210/en.2008-0721 · Cited by 89
Hanada, R., Nakazato, M., Matsukura, S., Murakami, N., Yoshimatsu, H., & Sakata, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2081 · Cited by 88
Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones
Ni, X.-P., Butler, A. A., Cone, R. D., & Humphreys, M. H. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000249702.49854.fa · Cited by 88
Heinig, J. A., Keeley, F. W., Robson, P., Sower, S. A., & Youson, J. H. (1995) · General and Comparative Endocrinology · doi:10.1006/gcen.1995.1094 · Cited by 88
Hainerová, I. A., Larsen, L. H., Holst, B., Finková, M., Hainer, V., Lebl, J., Hansen, T. F., & Pedersen, O. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0352 · Cited by 88
Brown, K. S., Gentry, R. M., & Rowland, N. E. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00127-x · Cited by 87
Watanobe, H., Schiöth, H. B., Wikberg, J. E. S., & Suda, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0547 · Cited by 87
Inverse agonist activity of agouti and agouti-related protein
Chai, B.-X., Neubig, R. R., Millhauser, G. L., Thompson, D. A., Jackson, P. J., Barsh, G. S., Dickinson, C. J., Li, J.-Y., Lai, Y.-M., & Gantz, I. (2003) · Peptides · doi:10.1016/s0196-9781(03)00104-9 · Cited by 87
Chai, B., Li, J.-Y., Zhang, W., Newman, E. A., Ammori, J. B., & Mulholland, M. W. (2006) · Peptides · doi:10.1016/j.peptides.2006.05.005 · Cited by 87
Nicholson, J. R., Peter, J. ‐., Lecourt, A. ‐., Barde, Y. ‐., & Hofbauer, K. G. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01610.x · Cited by 87
Lawrence, C. B., & Rothwell, N. J. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00660.x · Cited by 87
Central Melanocortins and the Regulation of Weight During Acute and Chronic Disease
Marks, D. L. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.359 · Cited by 87
Tung, Y. C. L., Piper, S. J., Yeung, D., O’Rahilly, S., & Coll, A. P. (2006) · Endocrinology · doi:10.1210/en.2006-0866 · Cited by 86
Tao, Y., & Segaloff, D. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0367 · Cited by 86
Self-citationBreit, A., Wolff, K., Kalwa, H., Jarry, H., Büch, T., & Gudermann, T. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605982200 · Cited by 85
Stanley, S. A., Small, C. J., Kim, M. S., Heath, M., Seal, L., Russell, S. H., Ghatei, M. A., & Bloom, S. R. (1999) · Endocrinology · doi:10.1210/endo.140.11.7248 · Cited by 85
Mizuno, T. M., Kelley, K. A., Pasinetti, G. M., Roberts, J. L., & Mobbs, C. V. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2675 · Cited by 85
Binge Eating as a Phenotype of Melanocortin 4 Receptor Gene Mutations
Herpertz, S., Siffert, W., & Hebebrand, J. (2003) · New England Journal of Medicine · doi:10.1056/nejm200308073490615 · Cited by 85
Phillips-Singh, D., Li, Q., Takeuchi, S., Ohkubo, T., Sharp, P. J., & Boswell, T. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0755-8 · Cited by 84
Cole, S. A., Butte, N. F., Voruganti, V. S., Cai, G., Haack, K., Kent, J. W., Blangero, J., Comuzzie, A. G., McPherson, J. D., & Gibbs, R. A. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28514 · Cited by 83
Contreras, P. C., & Takemori, A. E. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21820-1 · Cited by 83
Molecular Determinants of Melanocortin 4 Receptor Ligand Binding and MC4/MC3 Receptor Selectivity
Nickolls, S. A., Cismowski, M., Wang, X., Wolff, M., Conlon, P. J., & Maki, R. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044974 · Cited by 82
Kask, A., Rägo, L., Wikberg, J. E. S., & Schiöth, H. B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00699-2 · Cited by 82
Alcoholism and obesity: overlapping neuropeptide pathways?
Thiele, T. E., Navarro, M., Sparta, D. R., Fee, J. R., Knapp, D. J., & Cubero, I. (2003) · Neuropeptides · doi:10.1016/j.npep.2003.10.002 · Cited by 81
Valli‐Jaakola, K., Lipsanen‐Nyman, M., Oksanen, L., Hollenberg, A. N., KONTULA, K. K., Bjørbæk, C., & Schalin‐Jäntti, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031182 · Cited by 81
Memory impairment induced by IL-1β is reversed by α-MSH through central melanocortin-4 receptors
Gonzalez, P. V., Schiöth, H. B., Lasaga, M., & Scimonelli, T. N. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.03.001 · Cited by 81
Corticotropin inhibits food intake in rats
Vergoni, A. V., Poggioli, R., & Bertolini, A. (1986) · Neuropeptides · doi:10.1016/0143-4179(86)90091-0 · Cited by 80
Vulliémoz, N. R., Xiao, E., Xia‐Zhang, L., Wardlaw, S. L., & Ferin, M. (2004) · Endocrinology · doi:10.1210/en.2004-1093 · Cited by 80
Skibicka, K. P., & Grill, H. J. (2008) · Endocrinology · doi:10.1210/en.2008-1316 · Cited by 80
da Silva, A. A., do Carmo, J. M., Kanyicska, B., Dubinion, J., Brandon, E., & Hall, J. E. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100636 · Cited by 79
Fekete, C., Marks, D. L., Sarkar, S., Emerson, C. H., Rand, W. M., Cone, R. D., & Lechan, R. M. (2004) · Endocrinology · doi:10.1210/en.2004-0476 · Cited by 79
Melanocortin Receptor Variants with Phenotypic Effects in Horse, Pig, and Chicken
Andersson, L. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03195.x · Cited by 78
Melanocortin receptors form constitutive homo- and heterodimers
Mandrika, I., Petrovska, R., & Wikberg, J. E. S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.036 · Cited by 78
Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist
Skúladóttir, G. V., Jónsson, L., Skarphedinsson, J. O., Mutulis, F., Muceniece, R., Raine, A., Mutule, I., Helgason, J., Prūsis, P., Wikberg, J. E. S., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702264 · Cited by 78
Agouti-related protein in the hypothalamic paraventricular nucleus: effect on feeding
Wirth, M. M., & Giraudo, S. Q. (2000) · Peptides · doi:10.1016/s0196-9781(00)00280-1 · Cited by 77
Regulation of thermogenesis by the central melanocortin system
Fan, W., Voss-Andreae, A., Cao, W.-H., & Morrison, S. F. (2005) · Peptides · doi:10.1016/j.peptides.2004.11.033 · Cited by 77
Lubrano-Berthelier, C., Cavazos, M. M., Stunff, C. L., Haas, K. Z., Shapiro, A., Zhang, S., Bougneres, P. F., & Vaisse, C. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2996 · Cited by 77
Sánchez, E., Rubio, V. C., Thompson, D. A., Metz, J. R., Flik, G., Millhauser, G. L., & Cerdá‐Reverter, J. M. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90948.2008 · Cited by 76
Melanocortin-4 receptor mRNA expression in the developing autonomic and central nervous systems
Mountjoy, K. G., & Wild, J. M. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(98)00015-7 · Cited by 75
Functional and phylogenetic analyses of a melanocortin-4 receptor mutation in domestic pigs
Kim, K.-S., Reecy, J. M., Hsu, W. H., Anderson, L. L., & Rothschild, M. F. (2003) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2003.12.001 · Cited by 75
Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice
Weide, K., Christ, N., Moar, K. M., Arens, J., Hinney, A., Mercer, J. G., Eiden, S., & Schmidt, I. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00129.2002 · Cited by 74
Hernández‐Sánchez, J., Visscher, P. M., Plastow, G. S., & Haley, C. (2003) · Genetics · doi:10.1093/genetics/164.2.637 · Cited by 74
van der Kraan, M., Tatro, J. B., Entwistle, M. L., Brakkee, J. H., Burbach, J. P. H., Adan, R. A. H., & Gispen, W. H. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00291-5 · Cited by 73
Forebrain melanocortin signaling enhances the hindbrain satiety response to CCK-8
Blevins, J. E., Morton, G. J., Williams, D. L., Caldwell, D. W., Bastian, L. S., Wisse, B. E., Schwartz, M. W., & Baskin, D. G. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90544.2008 · Cited by 73
Obesity-associated mutations in the human melanocortin-4 receptor gene
MacKenzie, R. G. (2005) · Peptides · doi:10.1016/j.peptides.2005.03.064 · Cited by 73
Intraventricular administration of MSH induces hyperalgesia in rats
Sandman, C. A., & Kastin, A. J. (1981) · Peptides · doi:10.1016/s0196-9781(81)80040-x · Cited by 73
Kublaoui, B. M., Holder, J. L., Tolson, K. P., Gemelli, T., & Zinn, A. R. (2006) · Endocrinology · doi:10.1210/en.2006-0453 · Cited by 72
Hansen, M. J., Ball, M. J., & Morris, M. J. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03246-7 · Cited by 72
Melanocortin‐4 receptor expression in a vago‐vagal circuitry involved in postprandial functions
Gautron, L., Lee, C., Funahashi, H., Friedman, J. M., Lee, S., & Elmquist, J. K. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22221 · Cited by 72
Tarnow, P., Schöneberg, T., Krude, H., Grüters, A., & Biebermann, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309941200 · Cited by 70
Newman, E. A., Chai, B., Zhang, W., Li, J.-Y., Ammori, J. B., & Mulholland, M. W. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.02.003 · Cited by 70
Melanocortin peptides affect the motivation to feed in rainbow trout (Oncorhynchus mykiss)
Schjolden, J., Schiöth, H. B., Larhammar, D., Winberg, S., & Larson, E. T. (2008) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2008.11.003 · Cited by 69
Homozygous Null Mutation of the Melanocortin-4 Receptor and Severe Early-Onset Obesity
Dubern, B., Bisbis, S., Talbaoui, H., Beyec, J. L., Tounian, P., Lacorte, J., & Clément, K. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.01.041 · Cited by 69
Role of α-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation
Lasaga, M., Debéljuk, L., Durand, D., Scimonelli, T. N., & Caruso, C. M. (2008) · Peptides · doi:10.1016/j.peptides.2008.06.009 · Cited by 69
Wessells, H., Hruby, V. J., Hackett, J. T., Han, G. U., Balse, P., & Vanderah, T. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00866-7 · Cited by 68
Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation
Kuo, J. J., da Silva, A. A., Tallam, L. S., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000111836.54204.93 · Cited by 68
Nicholson, J. R., Kohler, G., Schaerer, F., Senn, C., Weyermann, P., & Hofbauer, K. G. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097725 · Cited by 68
Cheung, W. W., Kuo, H., Markison, S., Chen, C., Foster, A. C., Marks, D. L., & MAK, R. H. K. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091024 · Cited by 68
Roche, J. P., Bounds, S., Brown, S. M., & Mackie, K. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.3.611 · Cited by 68
Robert, J., Auzan, C., Ventura, M. A., & Clauser, É. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510180200 · Cited by 67
Alharbi, K. K., Spanakis, E., Tan, K. M. L., Smith, M. J., Aldahmesh, M. A., O’Dell, S. D., Sayer, A. A., Lawlor, D. A., Ebrahim, S. B. J., Smith, G. D., et al. (2006) · Human Mutation · doi:10.1002/humu.20404 · Cited by 67
Latronico, A. C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2435 · Cited by 67
Takeuchi, S., & Takahashi, S. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00165-7 · Cited by 66
Ringholm, A., Kloviņš, J., Fredriksson, R., Poliakova, N., Larson, E. T., Kukkonen, J. P., Larhammar, D., & Schiöth, H. B. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03371.x · Cited by 66
Tao, Y., Abell, A. N., Liu, X., Nakamura, K., & Segaloff, D. L. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.8.0503 · Cited by 66
Self-citationFekete, C., Légrádi, G., Mihály, E., Tatro, J. B., Rand, W. M., & Lechan, R. M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01256-8 · Cited by 66
Krakoff, J. A., Ma, L., Kobes, S., Knowler, W. C., Hanson, R. L., Bogardus, C., & Baier, L. J. (2008) · Diabetes · doi:10.2337/db08-0577 · Cited by 66
Garza, J. C., Kim, C. S., Liu, J., Zhang, W., & Lu, X.-Y. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0009 · Cited by 65
Yang, Y., Chen, M., Lai, Y., Gantz, I., Georgeson, K. E., & Harmon, C. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201343200 · Cited by 65
Kask, A., Rägo, L., Wikberg, J. E. S., & Schiöth, H. B. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00837-5 · Cited by 64
The melanocortin receptor MCR4 controls fat consumption
Samama, P., Rumennik, L., & Grippo, J. F. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00299-9 · Cited by 64
Rosmond, R., Chagnon, M., Bouchard, C., & Björntorp, P. A. (2001) · Diabetologia · doi:10.1007/s001250100649 · Cited by 63
Martí, A., Corbalán, M. S., Forga, L., Martínez, J. A., Hinney, A., & Hebebrand, J. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802244 · Cited by 63
Kobayashi, Y., Tsuchiya, K., Yamanome, T., Schiöth, H. B., Kawauchi, H., & Takahashi, A. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.05.010 · Cited by 63
Evolutionary Aspects in Evaluating Mutations in the Melanocortin 4 Receptor
Stäubert, C., Tarnow, P., Brumm, H., Pitra, C., Gudermann, T. W., Grüters, A., Schöneberg, T., Biebermann, H., & Römpler, H. (2007) · Endocrinology · doi:10.1210/en.2007-0138 · Cited by 63
Azzara, A. V., Sokolnicki, J. P., & Schwartz, G. J. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00883-1 · Cited by 62
Fan, J., Perry, S. J., Gao, Y., Schwarz, D. A., & Maki, R. A. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0301 · Cited by 62
Tanaka, T., Masuzaki, H., Yasue, S., Ebihara, K., Shiuchi, T., Ishii, T., Arai, N., Hirata, M., Yamamoto, H., Hayashi, T., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.04.004 · Cited by 62
Mountjoy, K. G., Wu, C., Dumont, L. M., & Wild, J. M. (2003) · Endocrinology · doi:10.1210/en.2003-0570 · Cited by 61
Marks, D. L., Boucher, N., Lanouette, C., Përusse, L., Brookhart, G., Comuzzie, A. G., Chagnon, Y. C., & Cone, R. D. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20600 · Cited by 61
Syndecan‐3 Modulates Food Intake by Interacting with the Melanocortin/AgRP Pathway
Reizes, O., Benoit, S. C., Strader, A. D., Clegg, D. J., Akunuru, S., & Seeley, R. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03163.x · Cited by 61
Melanocortin-4 receptors, β-MSH and leptin: Key elements in the satiety pathway
Harrold, J. A., & Williams, G. (2005) · Peptides · doi:10.1016/j.peptides.2005.01.030 · Cited by 61
Park, H. B., Carlborg, Ö., Marklund, S., & Andersson, L. (2002) · Animal Genetics · doi:10.1046/j.1365-2052.2002.00824.x · Cited by 61
Role of melanocortin signaling in the regulation of the hypothalamic–pituitary–thyroid (HPT) axis
Lechan, R. M., & Fekete, C. (2005) · Peptides · doi:10.1016/j.peptides.2005.01.033 · Cited by 60
Association of the MC4R V103I Polymorphism With the Metabolic Syndrome: The KORA Study
Heid, I. M., Vollmert, C., Kronenberg, F., Huth, C., Ankerst, D. P., Luchner, A., Hinney, A., Brönner, G., Wichmann, H. ‐., Illig, T., et al. (2008) · Obesity · doi:10.1038/oby.2007.21 · Cited by 60
Reduction in corpora lutea number in obese melanocortin-4-receptor-deficient mice
Sandrock, M., Schulz, A., Merkwitz, C., Schöneberg, T., Spanel‐Borowski, K., & Ricken, A. M. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-24 · Cited by 60
Oosterom, J., Nijenhuis, W. A. J., Schaaper, W. M. M., Slootstra, J. W., Meloen, R. H., Gispen, W. H., Burbach, J. P. H., & Adan, R. A. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16853 · Cited by 59
Expression of Functional Melanocortin-4 Receptor in the Hypothalamic GT1-1 Cell Line
Khong, K., Kurtz, S. E., Sykes, R., & Cone, R. D. (2001) · Neuroendocrinology · doi:10.1159/000054686 · Cited by 59
Therapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic disease
DeBoer, M. D., & Marks, D. L. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0221 · Cited by 58
Matsuda, K., Kojima, K., Shimakura, S.-I., Wada, K., Maruyama, K., Uchiyama, M., Kikuyama, S., & Shioda, S. (2008) · Peptides · doi:10.1016/j.peptides.2008.06.028 · Cited by 58
Mohammad, S., Baldini, G., Granell, S., Narducci, P., Martelli, A. M., & Baldini, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608283200 · Cited by 58
Central Melanocortin Receptors Mediate Changes in Food Intake in the Rhesus Macaque
Koegler, F. H., Grove, K. L., Schiffmacher, A. T., Smith, M. S., & Cameron, J. L. (2001) · Endocrinology · doi:10.1210/endo.142.6.8198 · Cited by 57
Molecular and Behavioral Interactions Between Central Melanocortins and Cocaine
Alvaro, J. D., Taylor, J. R., & Duman, R. S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040311 · Cited by 57
Melanocortins and opiate addiction
Alvaro, J. D., Tatro, J. B., & Duman, R. S. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00029-5 · Cited by 57
Kokare, D. M., Chopde, C. T., & Subhedar, N. K. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.011 · Cited by 56
Modulation of melanocortin signaling ameliorates uremic cachexia
Cheung, W. W., Rosengren, S., Boyle, D. L., & MAK, R. H. K. (2008) · Kidney International · doi:10.1038/ki.2008.150 · Cited by 56
van Calker, D., Löffler, F., & Hamprecht, B. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb11299.x · Cited by 56
Stachowiak, M., Szydłowski, M., Obarzanek-Fojt, M., & Switonski, M. (2005) · Animal Genetics · doi:10.1111/j.1365-2052.2005.01373.x · Cited by 56
Melanocortin 4 Receptor Gene Variation Is Associated With Severe Obesity in Pima Indians
Ma, L., Tataranni, P. A., Bogardus, C., & Baier, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2696 · Cited by 56
Buono, P., Pasanisi, F., Nardelli, C., Ieno, L., Capone, S., Liguori, R., Finelli, C., Oriani, G., Contaldo, F., & Sacchetti, L. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.047886 · Cited by 56
Li, G., Zhang, Y., Wilsey, J., & Scarpace, P. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1820123 · Cited by 56
Cachexia: lessons from melanocortin antagonism
DeBoer, M. D., & Marks, D. L. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.05.005 · Cited by 55
Navarro, M., Cubero, I., Chen, A. S., Chen, H. Y., Knapp, D. J., Breese, G. R., Marsh, D. J., & Thiele, T. E. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000167740.19702.8c · Cited by 55
Kokare, D. M., Singru, P. S., Dandekar, M. P., Chopde, C. T., & Subhedar, N. K. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.064 · Cited by 55
Barb, C. R., Robertson, A., Barrett, J., Kraeling, R. R., & Houseknecht, K. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1810039 · Cited by 55
Melanocortin Receptors as Targets in the Treatment of Obesity
Heisler, L. K., Farooqi, I. S., & Lam, D. D. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780906564 · Cited by 55
Gao, X., & van den Pol, A. N. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.019372 · Cited by 55
Hermans, E., Challiss, R. A. J., & Nahorski, S. R. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702359 · Cited by 54
Ward, D. R., Dear, F. M., Ward, I. A., Anderson, S., Spergel, D. J., Smith, P. A., & Ebling, F. J. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005322 · Cited by 54
Irani, B. G., Xiang, Z., Moore, M. C., Mandel, R. J., & Haskell‐Luevano, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.084 · Cited by 54
Li, G., Zhang, Y., Wilsey, J. T., & Scarpace, P. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1943-8 · Cited by 54
Rescuing the Traffic-Deficient Mutants of Rat μ-Opioid Receptors with Hydrophobic Ligands
Chaipatikul, V., Erickson, L. J., Loh, H. H., & Law, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.32 · Cited by 54
Deletions of the N‐terminal regions of the human melanocortin receptors
Schiöth, H. B., Petersson, S., Muceniece, R., Szardenings, M., & Wikberg, J. E. S. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00593-0 · Cited by 53
Weyermann, P., Dallmann, R., Magyar, J. P., Anklin, C., Hufschmid, M., Dubach‐Powell, J., Courdier-Fruh, I., Henneböhle, M., Nordhoff, S., & Mondadori, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004774 · Cited by 53
Cettour-Rose, P., & Rohner‐Jeanrenaud, F. (2002) · Endocrinology · doi:10.1210/endo.143.6.8871 · Cited by 53
Skibicka, K. P., & Grill, H. J. (2008) · Endocrinology · doi:10.1210/en.2007-1754 · Cited by 52
Leptin secretion and hypothalamic neuropeptide and receptor gene expression in sheep
Sørensen, A., Adam, C. L., Findlay, P. A., Marie, M., Thomas, E. L., Travers, M. T., & Vernon, R. G. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00595.2001 · Cited by 52
MTII-induced reduction of voluntary ethanol drinking is blocked by pretreatment with AgRP-(83–132)
Navarro, M., Cubero, I., Knapp, D. J., & Thiele, T. E. (2003) · Neuropeptides · doi:10.1016/j.npep.2003.10.003 · Cited by 51
Kalange, A. S., Kokare, D. M., Singru, P. S., Upadhya, M. A., Chopde, C. T., & Subhedar, N. K. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.054 · Cited by 50
Zohar, M., & Salomon, Y. (1992) · Brain Research · doi:10.1016/0006-8993(92)90608-c · Cited by 50
do Carmo, J. M., Tallam, L. S., Roberts, J. V., Brandon, E. L., Biglane, J., da Silva, A. A., & Hall, J. E. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00187.2009 · Cited by 50
Kaushal, S., Noorwez, S. M., Malhotra, R., McDowell, J. H., Smith, K. A., & Krebs, M. P. (2004) · Investigative Ophthalmology & Visual Science · Cited by 49
Henry, B. A., Rao, A., Ikenasio, B. A., Mountjoy, K. G., Tilbrook, A. J., & Clarke, I. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02918-3 · Cited by 49
Hebebrand, J., Fichter, M. M., Gerber, G., Görg, T., Hermann, H., Geller, F., Schäfer, H., Remschmidt, H., & Hinney, A. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001053 · Cited by 49
Williams, D. L., Grill, H. J., Weiss, S., Baird, J.-P., & Kaplan, J. M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1022-5 · Cited by 49
Matsumura, K., Tsuchihashi, T., Abe, I., & Iida, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03045-7 · Cited by 49
Melanocortin receptors mediate α-MSH-induced stimulation of neurite outgrowth in neuro 2A cells
Adan, R. A. H., van der Kraan, M., Doornbos, R. P., Bär, P. R., Burbach, J. P. H., & Gispen, W. H. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00236-l · Cited by 49
Nickolls, S. A., Fleck, B. A., Hoare, S. R. J., & Maki, R. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083337 · Cited by 49
Ploj, K., Roman, E., Kask, A., Hyytiä, P., Schiöth, H. B., Wikberg, J. E. S., & Nylander, I. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00844-4 · Cited by 48
de Vaca, S. C., Kim, G.-Y., & Carr, K. D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-0998-1 · Cited by 48
Trevaskis, J. L., & Butler, A. A. (2005) · Endocrinology · doi:10.1210/en.2005-0492 · Cited by 48
Santini, F., Maffei, M., Ceccarini, G., Pelosini, C., Scartabelli, G., Rosellini, V., Chiellini, C., Marsili, A., Lisi, S., Tonacchera, M., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031175 · Cited by 48
Flagged first, then by citations
5 of the 507 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360
Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity
Timper, K., & Brüning, J. C. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.026609 · Cited by 851
Obesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654
Sex differences in the physiology of eating
Asarian, L., & Geary, N. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00446.2012 · Cited by 513
Emerging paradigms in GPCR allostery: implications for drug discovery
Wootten, D., Christopoulos, A., & Sexton, P. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4052 · Cited by 498
Metadata
- Authors
- Tao, Y.-X.
- Affiliations
- Auburn University (US)
- Corresponding author
- Tao, Ya-Xiong
- ORCID
- Tao, Ya-Xiong
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2010-08-01
- Volume
- 31
- Issue
- 4
- Pages
- 506-543
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC3365848
- OpenAlex
- W2120361515
- Cited by
- 531
- References
- 507
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 34 · 2023: 34 · 2022: 31 · 2021: 41 · 2020: 41 · 2019: 33 · 2018: 29 · 2017: 32 · 2016: 21 · 2015: 29 · 2014: 39 · 2013: 47 · 2012: 30
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R15DK077213)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- melanocortin-4 receptor, energy homeostasis, monogenic obesity, MC4R mutations, cachexia, cardiovascular function, glucose homeostasis, lipid homeostasis, drug abuse, pain perception, neuroinflammation, anxiety, receptor pharmacology, ligand binding, receptor signaling pathways, pharmacological chaperones, obesity pathogenesis, small molecule drugs
- MeSH terms
- Amino Acid Sequence, Animals, Cachexia, Cardiovascular System, Cloning, Molecular, Energy Metabolism, Gene Expression Regulation, Glucose, Homeostasis, Humans, Molecular Sequence Data, Mutation, Obesity, Organ Specificity, Reproduction, Sexual Behavior, Signal Transduction, Sequence Alignment, Receptor, Melanocortin, Type 4, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review